526139 — Transgene Biotek Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹289.44m
- IN₹428.92m
- IN₹2.35m
Annual cashflow statement for Transgene Biotek, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -110 | -104 | -104 | -60.1 | -6.55 |
| Depreciation | |||||
| Non-Cash Items | 2.05 | 0.909 | 0.514 | 0.06 | -0.463 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10 | 4.48 | 5.24 | 10.5 | 6.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.39 | 0.126 | 0.978 | 0.002 | 0.046 |
| Capital Expenditures | — | -0.274 | -0.018 | -0.108 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -0.95 | -0.015 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.274 | -0.969 | -0.123 | 0 |
| Financing Cash Flow Items | 0 | — | — | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2 | 0 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.606 | -0.148 | 0.009 | -0.121 | 0.046 |